Figure 1A shows that there is a very low frequency of somatic mutations or copy number variations (CNV) in glioma samples for all the genes included in the study. The higher percentage of genetic alterations was found in the C9orf7 gene (3%), mainly associated with deep deletions that, in any case, are not frequently found in ALS patients. The gene discussed is CACFD1; the disease is glioma.